By Jacqueline Howard / CNN
There's no question that the impact of diseases varies drastically across the United States, depending on which state you live in.
By Steven Ross Johnson / Modern Healthcare
By EurekAlert!
Midway into a study in which all participants are offered use of a monthly vaginal ring containing an antiretroviral (ARV) drug called dapivirine, researchers have seen women's risk of acquiring HIV reduced by more than half.
By Sabrina Richards / Fred Hutch News Service
Dr. Paul Farmer, global health and human rights activist, founder of the nonprofit Partners in Health, and a Harvard anthropologist and medical professor, was recently in Seattle and took time out for a two-hour open Q&A session with UW students that centered on equity as the key to global health.
By Agnes Kyotalengerire / New Vision
The three-day meeting attracted investigators from the six collaborating countries of Kenya, Malawi, Uganda, Burkina Faso, Bangladesh and Pakistan who admit malnourished children, follow them through hospitalization and then six months after.
By Matt Day / The Seattle Times
The three U.S. corporate giants say their new venture will work to improve employee care and lower costs "free from profit-making incentives and constraints."
Amazon — thought for years to be weighing an entry into health care — landed there with an unexpected splash Tuesday, revealing plans to form a joint venture with Warren Buffett’s Berkshire Hathaway and JPMorgan Chase that’s charged with lowering the cost of caring for employees.
By Molly Walker / MedPage Today
Certain types of vaginal bacteria were associated with an increased risk of HIV infection among women, a nested case-control study of African women found.
By Clinton Leaf / Fortune
The 2018 World Economic Forum in Davos, Switzerland, just wrapped up a short time ago. Here are a few things I learned over the past week during this gathering of globally minded leaders, thinkers, builders, connectors, and teachers.
By Melissa Matthews / Newsweek
You’ve likely never heard of, or been tested for it, but a sexually transmitted infection that’s fairly common could now be resistant to antibiotic medications. Mycoplasma genitalium, or MG, is not a new bacteria and was first identified in the 1980s. According to the Centers for Disease Control and Prevention, it is more common than gonorrhea and chlamydia, though it's not as easily recognized as the other two.